VICC Seminar Series
The VICC Seminar Series is held on Thursdays throughout the academic year.
Watch past lectures
**Requires VUnetID/password and a browser that supports Silverlight technology (e.g., Internet Explorer, Mozilla Firefox for Windows).**
Fall 2018 - Spring 2019
Epigenetics of Cancer: Causes and novel treatment (Jan. 10, 2019)
Shelley Berger, Ph.D.
Daniel S. Och University Professor; Director, Epigenetics Institute
University of Pennsylvania
Using Pancreatic Organoids To Model, Detect, And Treat Cancer (Oct. 11, 2018)
Senthil Muthuswamy, Ph.D.
Chief, Division of Translational Research and Technology Innovation; Deputy Director, Translational Research; Director, Cell Biology Program
The Cancer Center at Beth Israel Deaconess Medical Center, Harvard Medical School
Patient Reported Outcomes: An Odyssey From Efficacy to Effectiveness to Implementation (Sept. 27, 2018)
Deborah Schrag, MD, MPH
Chief, Population Sciences; Attending Physician, Gastrointestinal Cancer Center; Professor of Medicine
Harvard Medical School
Fall 2017 - Spring 2018
Translating Chimerica Antigen Receptors into Solid Tumors (May 1, 2018)
Avery D. Posey, Jr., Ph.D.
University of Pennsylvania
Colorectal Cancer Risk: Insights into the Underlying Mechanisms and Biology (Apr. 12, 2018)
Graham Casey, PhD
Professor, Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia School of Medicine
The Pathways Study: a Multi-Level Prospective Cohort Study of Breast Cancer Survivorship, Prognosis and Outcomes (Mar. 22, 2018)
Lawrence Kushi, ScD
Director of Scientific Policy, Division of Research, Kaiser Permanente, Oakland, CA
Codon bias: The silent secret of RAS oncogenes (Mar. 15, 2018)
Christopher Counter, PhD
Professor of Pharmacology and Cancer Biology, Duke University School of Medicine
More than pretty pictures: Development of multiplexed tissue assays to support breast cancer clinical trials (Feb. 22, 2018)
Jennifer Giltnane, MD, PhD
Physician-Scientist, Anatomic Pathology & Laboratory Medicine, Genentech
Resistance to Immunotherapy – Lessons Learned from Genitourinary Cancers (Feb. 8, 2018)
Charles Drake, MD, PhD
Directory, Genitourinary Oncology
Co-Director, Immunotherapy Program
Associate Director, Clinical Research
Herbert Irving Comprehensive Cancer Center
New York-Presbyterian/Columbia University Medical Center
Tackling pancreatic cancer from many directions (Jan. 30, 2018)
Lynn Matrisian, PhD, MBA
Chief Science Officer
Pancreatic Cancer Action Network
Maintaining our genomes: whenever, wherever (Jan. 25, 2018)
Agnel Sfeir, PhD
Associate Professor, Department of Cell Biology
Skirball Institute, NYU Langone
Bridging the Chasm between Genomic Discovery & Translation: Communication, Behavior & Care Delivery (Jan. 11, 2018)
Anita Y. Kinney, Ph.D., RN, FAAN
Professor, Division of Epidemiology, Dept of Internal Medicine, Associate Director for Population Sciences
University of New Mexico Health Sciences Center
Accelerating CART Cells from the Model T to Driverless (Nov. 16, 2017)
Avery D. Posey, Jr., Ph.D.
Department of Pathology and Laboratory Medicine
University of Pennsylvania
Preclinical Targeting of Breast Cancer Metastasis: Through the TGF-β Lens (Nov. 9, 2017)
Lalage Wakefield, D.Phil
Lab of Cancer Biology and Genetics
National Cancer Institute
Opportunities and Challenges for Pancreatic Cancer Clinical Trials (Oct. 27, 2017)
M. Shaalan Beg, M.D.
MD Dedman Family Scholar in Clinical Care Medical Director
Clinical Research Office Co-Leader
GI Oncology Harold Simmons Cancer Center
UT Southwestern Medical Center
Thymidylate Synthase as a Chemotherapeutic Target in the Treatment of Colorectal Cancer (Oct. 19, 2017)
Edward Chu, M.D.
Professor of Medicine and Pharmacology & Chemical Biology
Stanley M. Marks-OHA Chair in Hematology-Oncology Research
Division of Hematology-Oncology Deputy Director
UPMC Hillman Cancer Center University of Pittsburgh School of Medicine
Fall 2016 - Spring 2017
Identification of Targetable Proteins and Processes Downstream of Steroid Receptors in Breast Cancer (May 11, 2017)
Donald P. McDonnell, Ph.D.
Glaxo-Wellcome Professor of MCB and Chairman; Department of Pharmacology and Cancer Biology; Professor of Medicine
Duke University School of Medicine
A New Home for the Epigenetic Machinery: SET-ing Methyl Marks on Microtubules (Apr. 13, 2017)
Cheryl Walker, Ph.D.
Center for Precision Environmental Health
Baylor College of Medicine, Houston, TX
Drug Development in the Era of Genomics and Immunotherapy (Apr. 7, 2017)
Alex Adjei, M.D., Ph.D.
Professor of Oncology
Mayo Clinic, Rochester, MN
Augmenting and broadening T-cell responses against mutated tumour new-antigens (Apr. 6, 2017)
Bruce WSRobinson, AM, CitWA, MBBS, MD, FRACP, FRCP, DTM& H, FCCP
Professor of Medicine, School of Medicine and Pharmacology, Director, TheFathering Project, UWA
School of Medicine and Pharmacology, Harry PerkinsInstitute, Sir Charles Gairdner Hospital, Nedlans, Perth, Australia
Predictors of response to immune checkpoint therapy in solid tumors (Mar. 30, 2017)
Gyan Bhanot, Ph.D.
Professor of Department of Molecular Biology and Biochemistry
SWI/SNF (BAF) Chromatin Remodeling Complexes are Frequently Mutated in Cancer: Mechanisms and Vulnerabilities (Mar. 9, 2017)
Charles M. Roberts, M.D.
Cancer Center Director and EVP
St. Jude Children’s Research Hospital
Population and Tumor Heterogeneity in Cancer Genome Scienceand Precision Oncology (Feb. 23, 2017)
John D. Carpten, Ph.D.
Professor, Department of Urology; Chair, Department of Translational Genomics; Director, USC Institute of Translational Genomics
USC Keck School of Medicine
For better or for worse: Immune modulation of pancreatic cancer (Dec. 15, 2016)
Steven D. Leach, M.D.
David M. Rubenstein Chair and Director, Rubenstein Center for Pancreatic Cancer Research
Memorial Sloan Kettering Cancer Center, New York, NY
Lymphoplegia in cancer treatment: The role of HMGB1 and mitochondria in tumor infiltrating lymphocytes (Oct.3, 2016)
Michael T. Lotze, M.D.
Professor of Surgery, Immunology, and Bioengineering; Assistant Vice Chancellor
University of Pittsburgh Schools of the Health Sciences
Triumphs and Challenges in Treating Metastatic Melanoma (Sept. 29, 2016) - Video not available
Harriet Kluger, M.D.
Professor of Medicine and Medical Oncology
Psychosocial Oncology Care: Variations on a Complex Theme (Sept. 15, 2016)
Donald Rosenstein, M.D.
Professor, Department of Psychiatry and Medicine; Director, Comprehensive Cancer Support Program
University of North Carolina, Chapel Hill, SC
Fall 2015 - Spring 2016
Risk Models and Cancer Prevention (May 12, 2016)
Mitch Gail, M.D., Ph.D.
Senior Investigator, National Cancer Institute Division of Cancer Epidemiology and Genetics, Biostatistics Branch
Molecular Control of Metastatic Progression (April 28, 2016)
Sohail Tavazoie, M.D., Ph.D.
Associate Professor; Head, Laboratory of Systems Cancer Biology
The Rockefeller University
Viewing the Immune System Through the Lens of Gene Regulatory Networks (April 21, 2016)
Harinder Singh, Ph.D.
Professor of Pediatrics; Director, Division of Immunology; Director, Center for Systems Immunology
Cincinnati Children's Hospital
Biomarker Accessible and Chemically AddressableSubtypes of Neoplastic Disease (April 14, 2016)
Michael White, Ph.D.
Professor and Grant A. Dove Distinguished Chair for Research in Oncology
UT Southwestern Medical Center, Dallas, TX
Recruitment, Retention, Surgical and Medication Adherence Studies with African Americans: Lessons Learned (March 31, 2016)
Marvella E. Ford, Ph.D.
Professor, Department of Public Health Sciences
Associate Director, Cancer Disparities
Hollings Cancer Center,Medical University of South Carolina, Charleston
Hypoxia, Metabolism, and Tumor Progression (March 29, 2016)
M. Celeste Simon, Ph.D.
Scientific Director and Investigator, Abramson Cancer Research Institute
Professor, Cell and Developmental Biology
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
MicroDNAs, Histone Chaperones and MCM Homologs: New Windows into Genomic Instability (March 10, 2016)
Anindya Dutta, M.D., Ph.D.
Harry F. Byrd Professor and Chair, Department of Biochemistry & Molecular Genetics
Professor of Pathology
University of Virginia, Charlottesville, VA
Addressing Social Determinants of Cancer Health Disparities Using a Community-Based Participatory Approach(February 25, 2016)
Chanita Hughes-Halbert, Ph.D.
Associate Dean for Assessment and Evaluation, College of Medicine
Professor, Department of Psychiatry and Behavioral Sciences
Endowed Chair for Cancer Equity
Hollings Cancer Center, Medical University of South Carolina
(February 18, 2016) - Video not available
Timothy N. J. Bullock, Ph.D.
Associate Professor of Pathology
University of Virginia School of Medicine
Implementing Lung Cancer Screening: Why Does It Have To Be So Hard?(January 28, 2016)
Michael K. Gould, M.D., M.S.
Director for Health Services Research and Implementation Science
Kaiser Permanente Southern California
Use of Dual-Mode Cellular Imaging in Cancer Vaccine Development(January 21, 2016)
Jeff W.M. Bulte, M.S., Ph.D.
Russell H. Morgan Dept. of Radiology and Radiological Science
Cellular Imaging Section and Vascular Biology Program
Institute for Cell Engineering
The Johns Hopkins University School of Medicine
FoxO regulation and function in aging and development(January 14, 2016)
Patrick J. Hu, M.D., Ph.D.
Associate Professor, Departments of Internal Medicine and Cell & Developmental Biology
University of Michigan
Treating Melanoma with the Immune System(May 7, 2015)
Antoni Ribas, M.D., Ph.D.
Director,Tumor Immunology Program
Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Conferences & Special Events
"Cancer Immunotherapy: Advances and Challenges"
(May 17-18, 2017)
Third National Veterans Health Affairs Research Conference
Research affiliates without a VUnet ID can request access by submitting a ticket through our Support Portal. Please provide:
- Email address
- Summary: Enter “Request VUnetID"